市場調查報告書
商品編碼
1298852
非PVC輸液袋市場:2023-2028年全球行業趨勢、佔有率、規模、成長、機會和預測Non-PVC IV Bags Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
2022年,全球非PVC輸液袋市場規模達到17億美元。展望未來,IMARC Group預計,到2028年,市場規模將達到26億美元,在2023-2028年期間呈現7.5%的成長率(CAGR)。
非聚氯乙烯(non-PVC)靜脈注射(IV)袋是用聚丙烯、聚乙烯、共聚酯-醚和乙烯-醋酸乙烯薄膜製造的。它們專門用於包裝補液和儲存某些抗生素和鎮痛劑,供醫院和獸醫使用。此外,它們可以廣泛用於冷庫,而不會抑制儲存物品的品質和保存期限。與經常面臨藥物和容器相互作用問題的PVC靜脈輸液袋不同,這些袋子提供了更好的安全性,降低了污染的風險,提高了使用的便利性。因此,非PVC靜脈輸液袋在腸外營養、腫瘤學、化療和靶向藥物輸送方面有廣泛的應用。
該市場主要由大眾中不斷上升的醫院獲得性感染(HAI)的發生率所驅動。再加上需要靜脈注射抗生素的病人不斷湧入醫療機構,這為非PVC靜脈輸液袋的使用提供了動力。另外,由於單室非PVC靜脈輸液袋便於管理、運輸和處置,在靜脈滴注和其他混合物中的廣泛採用,也大大促進了產品銷售。除此之外,全球越來越多的照護端(POC)設施和對家庭護理設置的偏愛,特別是對老年人群,都對市場成長產生了有利的影響。由乙烯-醋酸乙烯(EVA)製成的靜脈輸液袋的不斷普及進一步推動了市場的發展。由於這些袋子對無孔基質有很好的粘附性,而且價格合理,所以它們在全球範圍內被醫療專業人士廣泛使用。其他一些為市場創造積極前景的因素包括對生物惰性醫療用品的需求增加,醫療基礎設施的大量發展和廣泛的研究與開發(R&D)活動。
The global non-PVC IV bags market size reached US$ 1.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.6 Billion by 2028, exhibiting a growth rate (CAGR) of 7.5% during 2023-2028.
Non-polyvinyl chloride (non-PVC) intravenous (IV) bags are manufactured using polypropylene, polyethylene, copolyester-ether, and ethylene-vinyl acetate films. They are specifically designed for packaging rehydration solutions and storing certain antibiotics and analgesics for hospital and veterinary usage. Moreover, they can be extensively utilized in cold storage without inhibiting the quality and shelf-life of the stored items. Unlike PVC IV bags that often face drug and container interaction problems, these bags provide improved safety, lowered risks of contamination and enhanced convenience of usage. As a result, non-PVC IV bags find extensive applications in parenteral nutrition, oncology, chemotherapy, and targeted drug deliveries.
The market is primarily driven by the rising incidences of hospital-acquired infections (HAIs) among the masses. Coupled with the increasing influx of patients requiring intravenous antibiotics across healthcare facilities, this has provided a boost to the uptake of non-PVC IV bags. Also, the widespread adoption of single-chambered non-PVC IV bags in IV drips and other mixtures due to their convenience of management, transportation, and disposal is significantly contributing to the product sales. In addition to this, the growing number of point-of-care (POC) facilities across the globe and the preference for home care setups, especially for the geriatric population, are favorably impacting the market growth. The market is further driven by the escalating popularity of IV bags made up of ethylene-vinyl acetate (EVA). Since these bags offer excellent adhesion to non-porous substrates at an affordable price point, they are widely utilized by healthcare professionals on the global level. Some of the other factors creating a positive outlook for the market include the augmenting demand for biologically inert medical supplies, considerable developments in the healthcare infrastructure and extensive research and development (R&D) activities.
IMARC Group provides an analysis of the key trends in each sub-segment of the global non-PVC IV bags market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on material, product, content, application and end user.
Ethylene Vinyl Acetate
Copolyester-ether
Polypropylene
Others
Multi Chamber
Single Chamber
Frozen Mixture
Liquid Mixture
Chemotherapy
Targeted Drug Delivery
Glucose Injection
Sodium Chloride Solution
Electrolyte Injection
Nutrient Injection
Others
Hospitals
Clinics
Emergency Service Centers
Ambulatory Surgical Centers
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being B. Braun Melsungen AG, Baxter International Inc., Becton Dickinson and Company, Fresenius SE & Co. KGaA, JW Life Science Co. Ltd., Kraton Corporation (DL Chemical Co. Ltd.), Medline Industries LP, Persico S.p.a., Sealed Air Corporation and Sippex IV bags.
Key Questions Answered in This Report
1. What was the size of the global non-PVC IV bags market in 2022?
2. What is the expected growth rate of the global non-PVC IV bags market during 2023-2028?
3. What are the key factors driving the global non-PVC IV bags market?
4. What has been the impact of COVID-19 on the global non-PVC IV bags market?
5. What is the breakup of the global non-PVC IV bags market based on the material?
6. What is the breakup of the global non-PVC IV bags market based on the product?
7. What is the breakup of the global non-PVC IV bags market based on content?
8. What is the breakup of the global non-PVC IV bags market based on the end user?
9. What are the key regions in the global non-PVC IV bags market?
10. Who are the key players/companies in the global non-PVC IV bags market?